Patients with bladder cancer are typically aged in their 70s or 80s and are often smokers. They frequently have competing comorbidities and are on concomitant medication. A newly published study by Noon et a} reports cancer-specific mortality (CSM) and competing other-cause mortality (OCM) for patients with all stages of primary diagnosed bladder cancer, the main findings being that fewer elderly patients receive radical therapy for muscle-invasive disease than their younger counterparts and that women with high-risk noninvasive disease have higher CSM rates than equivalent men.
展开▼
